Paradigm Asset Management CO LLC Gilead Sciences, Inc. Transaction History
Paradigm Asset Management CO LLC
- $265 Million
- Q2 2025
A detailed history of Paradigm Asset Management CO LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 900 shares of GILD stock, worth $106,065. This represents 0.04% of its overall portfolio holdings.
Number of Shares
900
Previous 10,600
91.51%
Holding current value
$106,065
Previous $1.19 Million
91.66%
% of portfolio
0.04%
Previous 0.48%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
2,328Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.98 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.46 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.42 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...